IBUPROFEN (I) IN ELDERLY HYPERTENSIVE PATIENTS WITH MILD RENAL IMPAIRMENT

被引:0
|
作者
JAIN, A
VARGAS, R
FUREY, SA
SCHACHTEL, BP
MCMAHON, FG
机构
[1] TULANE UNIV,CLIN RES CTR,NEW ORLEANS,LA 70118
[2] WHITEHALL LABS,NEW YORK,NY
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:138 / 138
页数:1
相关论文
共 50 条
  • [41] ASSOCIATED LIPID AND RENAL DISTURBANCES IN HYPERTENSIVE ELDERLY PATIENTS
    Lelia, S.
    Serban, C.
    Pacurari, A.
    Mozos, I.
    Dascau, C.
    Romosan, I.
    JOURNAL OF HYPERTENSION, 2010, 28 : E380 - E380
  • [43] Homocysteinemia in hypertensive patients with renal target organ damage (mild renal dysfunction)
    Robles, N. R.
    Munoz-Torrero, J. F. Sanchez
    Gallego, F. Garcia
    Gemio, J. Velasco
    Escola, J. M.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2008, 13 (05) : 196 - 199
  • [44] RISK OF IBUPROFEN-ASSOCIATED RENAL IMPAIRMENT
    MURRAY, MD
    BRATER, DC
    TIERNEY, WM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (02) : 158 - 158
  • [45] Homocysteinemia in hypertensive patients with renal target organ damage (mild renal dysfunction)
    Robles, N. R.
    Sanchez Munoz-Torrero, J. F.
    Garcia Gallego, F.
    Velasco, J.
    Escola, J. M.
    JOURNAL OF HYPERTENSION, 2007, 25 : S66 - S67
  • [46] ELIMINATION OF DIMETHYLARGININES IN HYPERTENSIVE PATIENTS WITH MILD TO MODERATE RENAL INSUFFICIENCY
    Ronden, R. A.
    Houben, A. J. H. M.
    Bakker, J. A.
    de Leeuw, P. W.
    Kroon, A. A.
    JOURNAL OF HYPERTENSION, 2010, 28 : E153 - E153
  • [47] Effects of candesartan on renal and cardiovascular outcomes in hypertensive patients with renal impairment.
    Suzuki, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 672A - 673A
  • [48] Use of renal risk drugs in hospitalised patients with mild to moderate renal impairment
    Salvesen, Blix Hege
    Kirsten, Viktil
    Tron, Moger
    Aasmund, Reikvam
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 205 - 205
  • [49] Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairment
    Lathia, C
    Fleming, GF
    Meyer, M
    Ratain, MJ
    Whitfield, L
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (02) : 121 - 126
  • [50] Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairment
    Chetan Lathia
    Gini F. Fleming
    Mark Meyer
    Mark J. Ratain
    Lloyd Whitfield
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 121 - 126